Lung Immunity Support Probiotic has demonstrated the ability to greatly enhance the production of an important anti-inflammatory interleukin such as IL-10.
From the test results of the product, it is shown that it is able to induce the synthesis of much higher amounts of IL-10 by splenocytes than the splenocyte control sample.*
All these in vitro immunological results demonstrate the strong anti-inflammatory potential of the Lung Immunity Support Probiotic. This, together with the results of clinical studies of the complex of polypeptides and lipopolysaccharides, which has been proven by Acad.
Bogdan Petrunov and his team, can "support" our immune system to deal with secondary bacterial pneumonia (Maria Nikolova et al., 2009), demonstrate the ability of Lung Immunity Support Probiotic to influences our immune system positively by acting as an anti-inflammatory upon initial encounter with a pathogenic microorganism (pathogenic bacteria, viruses and fungal agents) and as an additional effect leading to the formation of a specific immune response to the underlying bacteria leading to the development of pneumonia.*
*All statements herein have not been evaluated by the Food and Drug Administration. The products on this website were not intended to diagnose, treat, cure, or prevent any disease.